ArticleIranian journal of pharmaceutical research : IJPR2020

Naringenin Enhances the Anti-Cancer Effect of Cyclophosphamide against MDA-MB-231 Breast Cancer Cells Via Targeting the STAT3 Signaling Pathway.

Shokoofe Noori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.